✨ Medicines Distribution Consent




NEW ZEALAND GAZETTE, No. 115

9 SEPTEMBER 2010

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Abilify
Active Ingredient:
Aripiprazole 2mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify
Active Ingredient:
Aripiprazole 5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify
Active Ingredient:
Aripiprazole 10mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify
Active Ingredient:
Aripiprazole 15mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify
Active Ingredient:
Aripiprazole 20mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify
Active Ingredient:
Aripiprazole 30mg
Dosage Form:
Tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturers:
Otsuka Pharmaceutical Co Limited, Tokushima, Japan
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico
Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico

Product:
Abilify ODT
Active Ingredient:
Aripiprazole 10mg
Dosage Form:
Orodispersible tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico

Product:
Abilify ODT
Active Ingredient:
Aripiprazole 15mg
Dosage Form:
Orodispersible tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Manufacturing Company, Mayaguez, Puerto Rico



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 115





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
9 September 2010
Medicines, Distribution, Abilify, Aripiprazole